The Centers for Medicare and Medicaid Services ("CMS") published a final notice outlining the processes and procedures for the Transitional ...

President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...

The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...

The pause appears to apply to HHS agencies such as the U.S. Food and Drug Administration, the Centers for Medicare and Medicaid Services, the U.S. Centers for Disease Control and Prevention ...

Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The Trump administration’s Centers for Medicare and Medicaid Services (CMS) has signaled that it will be revamping the ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule.